Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-09 11:07 am Purchase |
2022-12-30 | 13G | Allogene Therapeutics, Inc. ALLO |
The Vanguard Group | 7,265,221 5.040% |
7,265,221 (New Position) |
Filing History |
| 2023-02-03 3:52 pm Purchase |
2022-12-31 | 13G | Allogene Therapeutics, Inc. ALLO |
STATE STREET CORP STT |
9,166,408 6.360% |
9,166,408 (New Position) |
Filing History |
| 2023-02-03 12:09 pm Purchase |
2022-12-31 | 13G | Allogene Therapeutics, Inc. ALLO |
BLACKROCK INC BLK |
8,886,572 6.200% |
8,886,572 (New Position) |
Filing History |
| 2022-04-07 4:11 pm Unchanged |
2022-03-31 | 13D | Allogene Therapeutics, Inc. ALLO |
PFIZER INC PFE |
22,032,040 15.400% |
0 (Unchanged) |
Filing History |
| 2022-02-14 5:20 pm Sale |
2021-12-31 | 13G | Allogene Therapeutics, Inc. ALLO |
Seaview Trust | 7,041,120 4.940% |
-299,747 (-4.08%) |
Filing History |
| 2022-02-14 3:36 pm Purchase |
2021-12-31 | 13G | Allogene Therapeutics, Inc. ALLO |
Arie Belldegrun, M.D. | 7,203,248 5.000% |
708,755 (+10.91%) |
Filing History |
| 2022-02-11 12:22 pm Sale |
2022-02-14 | 13G | Allogene Therapeutics, Inc. ALLO |
Capital Research Global Investors | 0 0.000% |
-12,640,338 (Position Closed) |
Filing History |
| 2022-02-11 11:19 am Sale |
2022-02-14 | 13G | Allogene Therapeutics, Inc. ALLO |
Capital International Investors | 1,728,252 1.200% |
-5,971,451 (-77.55%) |
Filing History |
| 2022-02-10 4:51 pm Sale |
2021-04-20 | 13G | Allogene Therapeutics, Inc. ALLO |
GILEAD SCIENCES INC GILD |
1,156,689 0.800% |
-6,330,000 (-84.55%) |
Filing History |
| 2022-01-18 4:50 pm Purchase |
2022-01-12 | 13D | Allogene Therapeutics, Inc. ALLO |
TPG GP A, LLC | 18,716,306 13.200% |
18,716,306 (New Position) |
Filing History |
| 2021-09-17 4:17 pm Unchanged |
2021-09-10 | 13D | Allogene Therapeutics, Inc. ALLO |
PFIZER INC PFE |
22,032,040 15.500% |
0 (Unchanged) |
Filing History |
| 2021-02-16 4:04 pm Purchase |
2021-02-16 | 13G | Allogene Therapeutics, Inc. ALLO |
Capital International Investors | 7,699,703 5.500% |
7,699,703 (New Position) |
Filing History |
| 2021-02-16 3:46 pm Purchase |
2021-02-16 | 13G | Allogene Therapeutics, Inc. ALLO |
Capital Research Global Investors | 12,640,338 9.000% |
6,097,660 (+93.20%) |
Filing History |
| 2021-02-12 2:32 pm Sale |
2020-12-31 | 13G | Allogene Therapeutics, Inc. ALLO |
Arie Belldegrun, M.D. | 6,494,493 4.600% |
-859,507 (-11.69%) |
Filing History |
| 2021-02-12 1:00 pm Sale |
2020-12-31 | 13G | Allogene Therapeutics, Inc. ALLO |
Seaview Trust | 7,340,867 5.200% |
-1,251,741 (-14.57%) |
Filing History |
| 2020-08-10 4:32 pm Sale |
2020-08-06 | 13D | Allogene Therapeutics, Inc. ALLO |
TPG Group Holdings (SBS) Advisors Inc. | 18,716,306 13.400% |
-1,000,000 (-5.07%) |
Filing History |
| 2020-07-10 4:40 pm Sale |
2020-06-25 | 13D | Allogene Therapeutics, Inc. ALLO |
TPG Group Holdings (SBS) Advisors Inc. | 19,716,306 14.200% |
-1,500,000 (-7.07%) |
Filing History |